In the Segal Cancer Centre, Nurse Clinician Erika Martinez speaks with a patient who has called the Symptom Management Hotline.
February 2018News

New hotline helps patients manage chemo symptoms

A new rapid-response hotline is in place for JGH cancer patients who are concerned about nausea, bleeding, fatigue, fever or other symptoms that may be related to their current chemotherapy.

READ MORE →
On the third floor of Pavilion B, where the hospital’s old operating rooms have been demolished to make way for a new Psychiatry In-Patient Care Unit, JGH Project Manager Julianne Desforges reviews architectural plans with Stéphane Richard, a mechanical technician with SNC Lavelin.
February 2018News

Toughest demolition in JGH history clears the way for new Psychiatry unit

The most complicated demolition project in the history of the JGH has been completed in Pavilion B, so that work can begin on a new Psychiatry In-patient Care Unit,.

READ MORE →
In the JGH Cancer Prevention Centre, Dr. Michael Dworkind (centre), Director of the Smoking Cessation Program, meets with Centre’s Director, Dr. Michael Pollak (right), and with Smoking Cessation Counsellor Joseph Erban.
Feature articlesFebruary 2018

JGH helping smokers to butt out across Quebec and Canada

As organizations across Quebec and Canada become increasingly interested in developing campaigns to help smokers kick the habit, many have been looking to the example set by the JGH Smoking Cessation Program.

READ MORE →
Participating in the news conference on research into Alzheimer’s disease were (from left) Anthony Housefather, MP for Mount Royal; Dr. Yves Joanette, Scientific Director of the CIHR Institute of Aging; Alan Maislin, President of the Board of Directors of CIUSSS West-Central Montreal; Dr. Yves Joanette; and Dr. Howard Chertkow, Senior LDI Investigator.
February 2018News

$2.5 million for research into Alzheimer’s disease and dementia

Researchers in the Lady Davis Institute are among investigators from across Canada who will share in new federal funding of $2.5 million for research into various types of dementia, including Alzheimer’s disease.

READ MORE →